SEC Form 4 · accession 0001209191-16-113453
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Essig
Director
Period of report
Apr 4, 2016
Accepted (ET)
Apr 6, 2016 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 4, 2016 | M | 42,150 | $36.80 | A | 1,002,469 | D | |
| Common StockF3,F2 | Apr 4, 2016 | S | 42,150 | $67.2598 | D | 960,319 | D | |
| Common StockF2 | Apr 5, 2016 | M | 41,140 | $36.80 | A | 1,001,459 | D | |
| Common StockF4,F2 | Apr 5, 2016 | S | 41,140 | $66.0808 | D | 960,319 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F6,F5 | $36.80 | Apr 4, 2016 | M | 42,150 | D | — | Dec 19, 2016 | Common Stock | 42,150 | 166,630 | D |
| Non-Qualified Stock Option (right to buy)F6,F5 | $36.80 | Apr 5, 2016 | M | 41,140 | D | — | Dec 19, 2016 | Common Stock | 41,140 | 125,490 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2Includes 473 shares of common stock issued as restricted stock pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $67.00 to $67.85.
- F4The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $65.83 to $66.70.
- F525% of the option grant vested on 12/19/2007 (the first anniversary of the grant date of 12/19/2006), and the remaining 75% vested monthly thereafter over 36 months.
- F6This option was previously reported as covering 200,000 shares at an exercise price of $42.53 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.